US20050271742A1 - Injectable calcium phosphate cements and the preparation and use thereof - Google Patents
Injectable calcium phosphate cements and the preparation and use thereof Download PDFInfo
- Publication number
- US20050271742A1 US20050271742A1 US11/129,066 US12906605A US2005271742A1 US 20050271742 A1 US20050271742 A1 US 20050271742A1 US 12906605 A US12906605 A US 12906605A US 2005271742 A1 US2005271742 A1 US 2005271742A1
- Authority
- US
- United States
- Prior art keywords
- calcium
- phosphate
- calcium phosphate
- aqueous solution
- cement particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C5/00—Filling or capping teeth
- A61C5/60—Devices specially adapted for pressing or mixing capping or filling materials, e.g. amalgam presses
- A61C5/62—Applicators, e.g. syringes or guns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/15—Compositions characterised by their physical properties
- A61K6/17—Particle size
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
- A61K6/69—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
- A61K6/838—Phosphorus compounds, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/849—Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
- A61K6/864—Phosphate cements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B12/00—Cements not provided for in groups C04B7/00 - C04B11/00
- C04B12/02—Phosphate cements
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B12/00—Cements not provided for in groups C04B7/00 - C04B11/00
- C04B12/02—Phosphate cements
- C04B12/025—Phosphates of ammonium or of the alkali or alkaline earth metals
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B14/00—Use of inorganic materials as fillers, e.g. pigments, for mortars, concrete or artificial stone; Treatment of inorganic materials specially adapted to enhance their filling properties in mortars, concrete or artificial stone
- C04B14/02—Granular materials, e.g. microballoons
- C04B14/36—Inorganic materials not provided for in groups C04B14/022 and C04B14/04 - C04B14/34
- C04B14/366—Phosphates, e.g. apatite
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B28/00—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
- C04B28/34—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B28/00—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
- C04B28/34—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders
- C04B28/344—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders the phosphate binder being present in the starting composition solely as one or more phosphates
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B28/00—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
- C04B28/34—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders
- C04B28/346—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders the phosphate binder being present in the starting composition as a mixture of free acid and one or more phosphates
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
- C04B2111/00474—Uses not provided for elsewhere in C04B2111/00
- C04B2111/00836—Uses not provided for elsewhere in C04B2111/00 for medical or dental applications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
- Y10T428/2993—Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]
Definitions
- the present invention is related to a calcium phosphate cement, and in particular a fast-setting calcium phosphate cement, for use in dental and bone prosthesis.
- CPC calcium phosphate cement
- the prior art calcium phosphate cements suffer one or more drawbacks as follows: 1) additives having a relatively poor bioactivity being required; 2) a complicated preparation process; 3) an undesired setting time or working time of CPC, which are difficult to be adjusted; 4) not capable of being set to a desired shape in water, blood or body fluid; and 5) poor initial strength after setting of the CPC.
- An object of the present invention is to provide a calcium phosphate cement.
- a further object of the present invention is to provide a method of treating a born or a tooth having a defect in a patient by using a calcium phosphate cement.
- a calcium phosphate cement prepared in accordance with the present invention comprises calcium phosphate particles having a diameter of 0.05 to 100 microns, wherein said calcium phosphate particles on their surfaces have whiskers or fine crystals having a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm.
- the inventors of the present invention are able to adjust the working time and/or the setting time of the calcium phosphate cement of the present invention to conform to requirements for various purposes.
- the calcium phosphate cement of the present invention is fast-setting, and is non-dispersive in water or an aqueous solution.
- FIG. 1 is a normalized particle amount (%) versus particle diameter (pm) plot showing a particle diameter distribution of a calcium phosphate cement (CPC) prepared in accordance with the following Example 6 of the present invention.
- CPC calcium phosphate cement
- FIG. 2 is a scanning electron microscopy (SEM) micrograph of the calcium phosphate cement prepared in accordance with Example 6 of the present invention.
- FIGS. 3 and 4 show the distributions of the lengths and the widths of the whiskers or fine crystals on surfaces of the calcium phosphate particles prepared in the following Example 6 of the present invention, respectively, which are determined directly from transmission electron microscopy (TEM).
- TEM transmission electron microscopy
- FIGS. 5 a to 5 c are photographs showing a conventional CPC paste injected into water via a syringe at 3, 10 and 30 seconds after the conventional CPC paste being formed.
- FIGS. 6 a to 6 c are photographs showing a CPC paste of the present invention injected into water via a syringe at 3, 10 and 30 seconds after the CPC paste being formed in accordance with the following Example 7.
- FIGS. 7 a to 7 c are photographs showing two cylinders prepared by separately molding a conventional CPC paste and a CPC paste of the present invention prepared in the following Example 7, which were taken at 5, 20 and 60 seconds after the two cylinders being immersed in the water.
- FIG. 8 is a TEM micrograph showing the calcium phosphate cement of the present invention prepared in the following Example 7.
- FIG. 9 is a TEM micrograph showing the calcium phosphate cement of the present invention prepared in the following Example 7.
- a suitable process for preparing the calcium phosphate cement of the present invention comprises mixing a calcium phosphate powder or small pieces of calcium phosphate with a wetting agent, and controlling growth of whiskers or fine crystals on surfaces of said calcium phosphate powder or small pieces of calcium phosphate by an controlling treatment.
- Suitable calcium phosphates for use as the calcium phosphate powder or small pieces of calcium phosphate in the present invention can be any known calcium phosphates such as calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, apatite, hydroxyapatite, a mixture thereof and an adduct thereof.
- calcium phosphates such as calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, apatite, hydroxyapatite,
- the shape of the calcium phosphate powder and the shape of the small pieces of calcium phosphate are not limited, which can be spherical or irregular; and the crystal structure thereof can be single crystal, polycrystal, mixed crystals, semi-crystal, or amorphous.
- the process for preparing the calcium phosphate cement preferably further comprises grinding the resulting product from the controlling treatment to form calcium phosphate particles having a diameter of 0.05 to 100 microns, wherein said whiskers or fine crystals have a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm.
- Said controlling treatment is a vacuuming treatment, an organic solvent treatment, a microwave treatment, a heating treatment, or any other treatments which can control growth of whiskers or fine crystals on surfaces of said calcium phosphate powder or small pieces of calcium phosphate.
- Said wetting agent is used to wet the calcium phosphate powder or small pieces of calcium phosphate, and preferably is a diluted aqueous solution containing phosphoric acid or phosphate.
- the amount of said wetting agent mixed with the calcium phosphate powder or small pieces of calcium phosphate in general, should be enough to wet substantially all the calcium phosphate powder or small pieces of calcium phosphate.
- said controlling treatment is the organic solvent treatment, where a water miscible organic solvent is added to the mixture of said wetting agent and said calcium phosphate powder or small pieces of calcium phosphate to form a paste for a subsequent processing step.
- said wetting agent is a diluted aqueous solution containing more than 20 ppm of phosphoric acid or phosphate, more preferably more than 50 ppm, and most preferably more than 100 ppm of phosphoric acid or phosphate.
- the process for preparing the calcium phosphate cement of the present invention comprises soaking said calcium phosphate powder or said small pieces of calcium phosphate with said diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate, and carrying out (a) said heating treatment comprising drying the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate at a temperature higher than 45° C.; (b) said vacuuming treatment comprising drying the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate under vacuum; or (c) said microwave treatment comprising drying the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate by microwave heating. More preferably, the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate is well mixed to form a uniform mixture prior to being subjected to treatment (a), (b) or (c).
- the process for preparing the calcium phosphate cement of the present invention comprises mixing said calcium phosphate powder or said small pieces of calcium phosphate with said diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate, and carrying out said organic solvent treatment comprising mixing the mixture of said wetting agent and said calcium phosphate powder or small pieces of calcium phosphate with a water miscible organic solvent, and drying the resulting mixture under vacuum.
- said organic solvent treatment is carried out while stirring, and more preferably, the mixture of said diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate and said calcium phosphate powder or small pieces of calcium phosphate is well mixed prior to being subjected to said organic solvent treatment.
- said calcium phosphate particles of the calcium phosphate cement of the present invention have a diameter of 0.2 to 80 microns, and more preferably 0.5 to 50 microns.
- the width of a whisker means an average value of lateral cross-sectional diameters of the whisker
- the width of a fine crystal means an average value of the first 30% of the diameters of the fine crystal, which are shorter than the other 70% thereof.
- the length of a fine crystal means an average value of the last 30% of the diameters of the fine crystal, which are longer than the other 70% thereof.
- said whiskers or fine crystals have a width ranging from 2 to 70 nm and a length ranging from 5 to 800 nm, and more preferably a length ranging from 10 to 700 nm.
- said calcium phosphate particles have a molar ratio of calcium to phosphate ranging from 0.5 to 2.5, more preferably 0.8 to 2.3, and most preferably 1.0 to 2.2.
- the calcium phosphate cement of the present invention is biocompatible and a paste made therefrom is non-dispersive in water, which has a working time from several minutes to hours and a setting time from a few minutes to hours. Consequently, the calcium phosphate cement of the present invention is extremely suitable for use as an implant or filling material in dental or bone prosthesis, where the paste must contact water, blood or body fluid. Particularly, the paste made from the calcium phosphate cement of the present invention is able to be directly injected into a bone defect or cavity as an implant or filling material.
- the present invention also discloses a method of treating a born or a tooth having a defect in a patient, comprising mixing the calcium phosphate cement of the present invention and a hardening-promoter-containing aqueous solution to form a paste, and a) injecting said paste into a bone defect or cavity of said patient or b) shaping said paste and implanting the resulting shaped paste into a bone defect or cavity of said patient.
- said calcium phosphate cement may further comprise a growth factor, a bone morphology protein or a pharmaceutical carrier, or said hardening-promoter-containing aqueous solution further comprises a growth factor, a bone morphology protein or a pharmaceutical carrier.
- Said hardening-promoter-containing aqueous solution can be an aqueous solution comprising any known compounds or compositions which enable the solidification of calcium phosphate, for examples phosphates, calcium salts, and fluorides. That is said hardening-promoter-containing aqueous solution may be an aqueous solution comprising phosphate ions, calcium ions, fluorine ions, or phosphate ions together with fluorine ions as a hardening promoter.
- the content of said hardening promoter in said hardening-promoter-containing aqueous solution has no special limitation, but preferably ranges from 1 mM to 3 M, and more preferably from 10 mM to 1 M.
- the mixing ratio of the calcium phosphate cement of the present invention and said hardening-promoter-containing aqueous solution is not restricted to any particular ranges; however, the amount of said hardening-promoter-containing aqueous solution mixed should be sufficient to provide substantial wetting of the calcium phosphate cement of the present invention. It should be noted that more water can be supplied in-situ from saliva or body fluid, when the paste is injected or implanted into the bone defect or cavity. Further, the content of said hardening promoter in said hardening-promoter-containing aqueous solution should be adjusted to a higher level corresponding to a less amount of said hardening-promoter-containing aqueous solution being mixed.
- the setting time is the time required when a 1 mm diameter pin with a load of 1 ⁇ 4 pounds can be inserted only 1 mm deep into the surface of the paste.
- the working time is the time after which the paste is too viscous to be stirred.
- the working time of the paste of this example is 30 minutes and the setting time thereof is one hour.
- the paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
- the paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
- the paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
- the paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
- the paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
- Example 1 The procedures of Example 1 were repeated except that the Ca(H 2 PO 4 ) 2 .
- H 2 O powder was replaced by a mixed powder of DCPA and TTCP in 1:1 molar ratio and the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96.
- the heating treatments were carried out with conditions listed in Table 1. The performance is also listed in Table 1.
- Example 2 The procedures of Example 2 were repeated except that the DCPA powder was replaced by a mixed powder of DCPA and TTCP in 1:1 molar ratio and the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96.
- the performance is listed in Table 1.
- Example 3 The procedures of Example 3 were repeated except that the DCPA powder was replaced by a mixed powder of DCPA and TTCP in 1:1 molar ratio and the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96.
- the performance is listed in Table 1.
- Example 4 The procedures of Example 4 were repeated except that the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96.
- the performance is listed in Table 1.
- the pastes prepared in Control Example 1 and Example 7 were injected into water via a syringe at 3, 10 and 30 seconds after the paste being formed. The results are shown in FIGS. 5 a to 5 c and FIGS. 6 a to 6 c, respectively. It can be seen from FIGS. 5 a to 5 b that the paste prepared in Control Example 1 is dispersive in water. On the contrary, the paste prepared in Example 7 is non-dispersive as shown in FIGS. 6 a to 6 c.
- FIGS. 7 a to 7 c show the pictures taken at 5, 20 and 60 seconds after the cylinders being immersed in the water, from which it can be seen that the left cylinder made from the paste prepared in Control Example 1 collapses, while the right cylinder made form the paste prepared in Example 7 remains almost intact.
- Example 7 Two samples of the calcium phosphate cement prepared in Example 7 were observed by transmission electron microscopy (TEM), and the two TEM pictures shown in FIGS. 8 and 9 indicate that there are whiskers on surfaces of calcium phosphate particles having different diameters of the calcium phosphate cement.
- TEM transmission electron microscopy
- the calcium phosphate cement prepared in Example 6 has a particle diameter distribution shown in FIG. 1 , which was determined by using particle size analyzer (Sald-2001, Shimadzu Co., Japan).
- the curve in FIG. 1 indicates that the particle diameters of the calcium phosphate cement prepared in Example 6 range from about 0.47 microns to 93.49 microns.
- FIG. 2 shows a scanning electron microscopy (SEM) micrograph of the calcium phosphate cement prepared in Example 6.
- the lengths and the widths of the whiskers or fine crystals on surfaces of the calcium phosphate particles prepared in Example 6 were determined directly from TEM (JXA-840, JEOL Co., Japan), and the results are shown in FIGS. 3 and 4 , respectively.
- the lengths and widths of the of the whiskers or fine crystals on surfaces of the calcium phosphate particles prepared in Example 6 range from 1 to 625 nm and 1 to 65 nm, respectively.
- Example 7 The procedures of Example 7 were repeated by using the calcium phosphate powders and the wetting solutions listed in Table 2. The performance is also listed in Table 2.
- TTCP + DCPA is a mixed powder of TTCP and DCPA in 1:1 molar ratio.
- TTCP + DCPA + TCP is a mixed powder of TTCP + DCPA and TCP in 1:1 weight ratio.
- DCPA + TCP is a mixed powder of DCPA and TCP in 1:2 molar ratio.
- DCPA + TCP is a mixed powder of DCPA and TCP in 1:2 molar ratio.
- Control Example 1 The procedures of Control Example 1 were repeated by using the calcium phosphate powders and the wetting solutions listed in Table 2. The performance is also listed in Table 2.
- Example 7 The procedures of Example 7 were repeated by using the wetting solutions having different pH values listed in Table 3. The performance is also listed in Table 3.
- Control Example 1 The procedures of Control Example 1 were repeated by using the wetting solutions having different pH values listed in Table 3. The performance is also listed in Table 3. TABLE 3 Heating Dispersive Wetting solution pH treatment in water Ex. 20 Phosphoric acid 0.56 Yes No Control Ex. 7 — — No Yes Ex. 21 Phosphoric acid 1.03 Yes No Ex. 22 Phosphoric acid 1.17 Yes No Ex. 23 Phosphoric acid 1.22 Yes No Ex. 24 Phosphoric acid 1.32 Yes No Ex. 25 Phosphoric acid 2.0 Yes No Control Ex. 8 — — No Yes Ex. 26 Acetic acid + sodium 7.0 Yes No carbonate Control Ex. 9 — — No Yes Ex. 27 Sodium hydroxide 9.5 Yes No Control Ex. 10 — — No Yes Ex.
Abstract
A calcium phosphate cement suitable for use in dental and bone prosthesis is disclosed, which include calcium phosphate particles having a diameter of 0.05 to 100 microns, wherein said calcium phosphate particles on their surfaces have whiskers or fine crystals having a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm.
Description
- This application is a continuation-in-part and claims the benefit of priority under 35 USC §120 of U.S. application Ser. No. 09/615,384, filed Jul. 13, 2000. The disclosure of the prior application is considered part of and is incorporated by reference in the disclosure of this application.
- 1. Field of the Invention
- The present invention is related to a calcium phosphate cement, and in particular a fast-setting calcium phosphate cement, for use in dental and bone prosthesis.
- 2. Description of the Related Art
- A calcium phosphate cement (abbreviated as CPC) has been widely used as an implant or filling material in dental and bone prosthesis, and its technical details can be found in many patents, for examples U.S. Pat. Nos. 4,959,104; 5,092,888; 5,180,426; 5,262,166; 5,336,264; 5,525,148; 5,053,212; 5,149,368; 5,342,441; 5,503,164; 5,542,973; 5,545,254; 5,695,729 and 5,814,681. In general, the prior art calcium phosphate cements suffer one or more drawbacks as follows: 1) additives having a relatively poor bioactivity being required; 2) a complicated preparation process; 3) an undesired setting time or working time of CPC, which are difficult to be adjusted; 4) not capable of being set to a desired shape in water, blood or body fluid; and 5) poor initial strength after setting of the CPC.
- An object of the present invention is to provide a calcium phosphate cement.
- Another object of the present invention is to provide a calcium phosphate cement comprising particles having whiskers or fine crystals on surfaces of the particles. Still another object of the present invention is to provide a process for preparing a calcium phosphate cement.
- A further object of the present invention is to provide a method of treating a born or a tooth having a defect in a patient by using a calcium phosphate cement.
- In order to accomplish the above objects of the present invention a calcium phosphate cement prepared in accordance with the present invention comprises calcium phosphate particles having a diameter of 0.05 to 100 microns, wherein said calcium phosphate particles on their surfaces have whiskers or fine crystals having a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm. By adjusting the diameter of the calcium phosphate particles, the width and/or the length of the whiskers or fine crystals, the inventors of the present invention are able to adjust the working time and/or the setting time of the calcium phosphate cement of the present invention to conform to requirements for various purposes. Moreover, the calcium phosphate cement of the present invention is fast-setting, and is non-dispersive in water or an aqueous solution.
-
FIG. 1 is a normalized particle amount (%) versus particle diameter (pm) plot showing a particle diameter distribution of a calcium phosphate cement (CPC) prepared in accordance with the following Example 6 of the present invention. -
FIG. 2 is a scanning electron microscopy (SEM) micrograph of the calcium phosphate cement prepared in accordance with Example 6 of the present invention. -
FIGS. 3 and 4 show the distributions of the lengths and the widths of the whiskers or fine crystals on surfaces of the calcium phosphate particles prepared in the following Example 6 of the present invention, respectively, which are determined directly from transmission electron microscopy (TEM). -
FIGS. 5 a to 5 c are photographs showing a conventional CPC paste injected into water via a syringe at 3, 10 and 30 seconds after the conventional CPC paste being formed. -
FIGS. 6 a to 6 c are photographs showing a CPC paste of the present invention injected into water via a syringe at 3, 10 and 30 seconds after the CPC paste being formed in accordance with the following Example 7. -
FIGS. 7 a to 7 c are photographs showing two cylinders prepared by separately molding a conventional CPC paste and a CPC paste of the present invention prepared in the following Example 7, which were taken at 5, 20 and 60 seconds after the two cylinders being immersed in the water. -
FIG. 8 is a TEM micrograph showing the calcium phosphate cement of the present invention prepared in the following Example 7. -
FIG. 9 is a TEM micrograph showing the calcium phosphate cement of the present invention prepared in the following Example 7. - A suitable process for preparing the calcium phosphate cement of the present invention comprises mixing a calcium phosphate powder or small pieces of calcium phosphate with a wetting agent, and controlling growth of whiskers or fine crystals on surfaces of said calcium phosphate powder or small pieces of calcium phosphate by an controlling treatment.
- Suitable calcium phosphates for use as the calcium phosphate powder or small pieces of calcium phosphate in the present invention can be any known calcium phosphates such as calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, apatite, hydroxyapatite, a mixture thereof and an adduct thereof. Moreover, the shape of the calcium phosphate powder and the shape of the small pieces of calcium phosphate are not limited, which can be spherical or irregular; and the crystal structure thereof can be single crystal, polycrystal, mixed crystals, semi-crystal, or amorphous.
- The process for preparing the calcium phosphate cement preferably further comprises grinding the resulting product from the controlling treatment to form calcium phosphate particles having a diameter of 0.05 to 100 microns, wherein said whiskers or fine crystals have a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm.
- Said controlling treatment is a vacuuming treatment, an organic solvent treatment, a microwave treatment, a heating treatment, or any other treatments which can control growth of whiskers or fine crystals on surfaces of said calcium phosphate powder or small pieces of calcium phosphate.
- Said wetting agent is used to wet the calcium phosphate powder or small pieces of calcium phosphate, and preferably is a diluted aqueous solution containing phosphoric acid or phosphate. The amount of said wetting agent mixed with the calcium phosphate powder or small pieces of calcium phosphate, in general, should be enough to wet substantially all the calcium phosphate powder or small pieces of calcium phosphate. However, it is not necessarily the case when said controlling treatment is the organic solvent treatment, where a water miscible organic solvent is added to the mixture of said wetting agent and said calcium phosphate powder or small pieces of calcium phosphate to form a paste for a subsequent processing step.
- Preferably, said wetting agent is a diluted aqueous solution containing more than 20 ppm of phosphoric acid or phosphate, more preferably more than 50 ppm, and most preferably more than 100 ppm of phosphoric acid or phosphate.
- Preferably, the process for preparing the calcium phosphate cement of the present invention comprises soaking said calcium phosphate powder or said small pieces of calcium phosphate with said diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate, and carrying out (a) said heating treatment comprising drying the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate at a temperature higher than 45° C.; (b) said vacuuming treatment comprising drying the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate under vacuum; or (c) said microwave treatment comprising drying the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate by microwave heating. More preferably, the resulting soaked calcium phosphate powder or soaked small pieces of calcium phosphate is well mixed to form a uniform mixture prior to being subjected to treatment (a), (b) or (c).
- Alternatively, the process for preparing the calcium phosphate cement of the present invention comprises mixing said calcium phosphate powder or said small pieces of calcium phosphate with said diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate, and carrying out said organic solvent treatment comprising mixing the mixture of said wetting agent and said calcium phosphate powder or small pieces of calcium phosphate with a water miscible organic solvent, and drying the resulting mixture under vacuum. Preferably, said organic solvent treatment is carried out while stirring, and more preferably, the mixture of said diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate and said calcium phosphate powder or small pieces of calcium phosphate is well mixed prior to being subjected to said organic solvent treatment.
- Preferably, said calcium phosphate particles of the calcium phosphate cement of the present invention have a diameter of 0.2 to 80 microns, and more preferably 0.5 to 50 microns.
- The width of a whisker means an average value of lateral cross-sectional diameters of the whisker, and the width of a fine crystal means an average value of the first 30% of the diameters of the fine crystal, which are shorter than the other 70% thereof. The length of a fine crystal means an average value of the last 30% of the diameters of the fine crystal, which are longer than the other 70% thereof.
- Preferably, said whiskers or fine crystals have a width ranging from 2 to 70 nm and a length ranging from 5 to 800 nm, and more preferably a length ranging from 10 to 700 nm.
- Preferably, said calcium phosphate particles have a molar ratio of calcium to phosphate ranging from 0.5 to 2.5, more preferably 0.8 to 2.3, and most preferably 1.0 to 2.2.
- The calcium phosphate cement of the present invention is biocompatible and a paste made therefrom is non-dispersive in water, which has a working time from several minutes to hours and a setting time from a few minutes to hours. Consequently, the calcium phosphate cement of the present invention is extremely suitable for use as an implant or filling material in dental or bone prosthesis, where the paste must contact water, blood or body fluid. Particularly, the paste made from the calcium phosphate cement of the present invention is able to be directly injected into a bone defect or cavity as an implant or filling material.
- The present invention also discloses a method of treating a born or a tooth having a defect in a patient, comprising mixing the calcium phosphate cement of the present invention and a hardening-promoter-containing aqueous solution to form a paste, and a) injecting said paste into a bone defect or cavity of said patient or b) shaping said paste and implanting the resulting shaped paste into a bone defect or cavity of said patient.
- In the method of the present invention, said calcium phosphate cement may further comprise a growth factor, a bone morphology protein or a pharmaceutical carrier, or said hardening-promoter-containing aqueous solution further comprises a growth factor, a bone morphology protein or a pharmaceutical carrier.
- Said hardening-promoter-containing aqueous solution can be an aqueous solution comprising any known compounds or compositions which enable the solidification of calcium phosphate, for examples phosphates, calcium salts, and fluorides. That is said hardening-promoter-containing aqueous solution may be an aqueous solution comprising phosphate ions, calcium ions, fluorine ions, or phosphate ions together with fluorine ions as a hardening promoter.
- The content of said hardening promoter in said hardening-promoter-containing aqueous solution has no special limitation, but preferably ranges from 1 mM to 3 M, and more preferably from 10 mM to 1 M.
- The mixing ratio of the calcium phosphate cement of the present invention and said hardening-promoter-containing aqueous solution is not restricted to any particular ranges; however, the amount of said hardening-promoter-containing aqueous solution mixed should be sufficient to provide substantial wetting of the calcium phosphate cement of the present invention. It should be noted that more water can be supplied in-situ from saliva or body fluid, when the paste is injected or implanted into the bone defect or cavity. Further, the content of said hardening promoter in said hardening-promoter-containing aqueous solution should be adjusted to a higher level corresponding to a less amount of said hardening-promoter-containing aqueous solution being mixed.
- 5 g of Ca(H2PO4)2.H2O powder and 1.6 ml of 25 mM phosphoric acid aqueous solution were mixed, and stirred for one minute. The resulting mixture was placed into an oven at 50° C. for 15 minutes, and the resulting dried mixture was mechanically ground for 20 minutes to fine particles after being removed from the oven. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The setting time is the time required when a 1 mm diameter pin with a load of ¼ pounds can be inserted only 1 mm deep into the surface of the paste. The working time is the time after which the paste is too viscous to be stirred. The working time of the paste of this example is 30 minutes and the setting time thereof is one hour.
- The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
- 5 g of CaHPO4 (DCPA) powder and 1.2 ml of 25 mM phosphoric acid aqueous solution were mixed, and stirred for one minute. The resulting mixture was placed in a vacuum environment of −100 Pa for 30 minutes, and the resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 20.5 minutes and the setting time thereof is 24 minutes.
- The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
- 5 g of CaHPO4 (DCPA) powder and 1.6 ml of 25 mM phosphoric acid aqueous solution were mixed, and stirred for one minute. To the resulting mixture 1.6 ml of acetone was added while stirring to form a paste followed by placing in a vacuum environment of −100 Pa for one hour, and the resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 20.0 minutes and the setting time thereof is 22.0 minutes.
- The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
- 3 g of a mixed powder of CaHPO4 (DCPA) and Ca4(PO4)2O (TTCP) in 1:1 molar ratio was mixed with 2.0 ml of 25 mM phosphoric acid aqueous solution, and the mixture was stirred for five minutes. The resulting mixture was placed in a microwave oven where it was heated under low power for five minutes. The resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.42 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 2.0 minutes and the setting time thereof is 4.0 minutes.
- The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
- 5 g of a mixed powder of DCPA and TTCP in 1:1 molar ratio was mixed with 1.6 ml of 25 mM phosphoric acid aqueous solution, and the mixture was stirred for one minute. The resulting mixture was placed in a high temperature oven at 500° C. for five minutes. The resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 1.5 minutes and the setting time thereof is 2.5 minutes.
- The paste was placed in a relatively large amount of deionized water immediately following the formation thereof, and it was observed that the paste was non-dispersive in deionized water.
- 5 g of a mixed powder of DCPA and TTCP in 1:1 molar ratio was mixed with 1.6 ml of 25 mM phosphoric acid aqueous solution, and the mixture was stirred for one minute. The resulting mixture was placed in a high temperature oven at 1000° C. for one minute. The resulting dried mixture was mechanically ground for 20 minutes to fine particles. 1 g of the fine particles and 0.4 ml of phosphate aqueous solution (1.0 M, pH=6.0) were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The working time of the paste of this example is 31 minutes and the setting time thereof is 35 minutes.
- The procedures of Example 1 were repeated except that the Ca(H2PO4)2. H2O powder was replaced by a mixed powder of DCPA and TTCP in 1:1 molar ratio and the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96. The heating treatments were carried out with conditions listed in Table 1. The performance is also listed in Table 1.
- 1 g of a mixed powder of DCPA and TTCP in 1:1 mole and 0.4 ml of a diluted phosphoric acid aqueous solution having a pH of 1.96 were mixed to form a paste, which was tested every 30 seconds to determine the working time and the setting time. The paste of this example can not set within hours. The performance is listed in Table 1.
- The procedures of Example 2 were repeated except that the DCPA powder was replaced by a mixed powder of DCPA and TTCP in 1:1 molar ratio and the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96. The performance is listed in Table 1.
- The procedures of Example 3 were repeated except that the DCPA powder was replaced by a mixed powder of DCPA and TTCP in 1:1 molar ratio and the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96. The performance is listed in Table 1.
- The procedures of Example 4 were repeated except that the 25 mM phosphoric acid aqueous solution was replaced by a diluted phosphoric acid aqueous solution having a pH of 1.96. The performance is listed in Table 1.
TABLE 1 Setting/working Dispersive Controlling treatment time (min) in Water Control Ex. 1 — — Yes Ex. 7 Heating, 50° C. 11.5/6.5 No Ex. 8 Heating, 100° C. 13.5/8.0 No Ex. 9 Heating, 150° C. 8.5/8.0 No Ex. 10 Heating, 500° C. 2.5/1.5 No Ex. 11 Heating, 1000° C. 35/31 No Ex. 12 Vacuuming 14.5/11.5 No Ex. 13 Organic solvent 17.5/16.5 No Ex. 14 Microwave 3.5/2.5 No - The pastes prepared in Control Example 1 and Example 7 were injected into water via a syringe at 3, 10 and 30 seconds after the paste being formed. The results are shown in
FIGS. 5 a to 5 c andFIGS. 6 a to 6 c, respectively. It can be seen fromFIGS. 5 a to 5 b that the paste prepared in Control Example 1 is dispersive in water. On the contrary, the paste prepared in Example 7 is non-dispersive as shown inFIGS. 6 a to 6 c. - Two cylinders were prepared by separately molding the pastes prepared in Control Example 1 and Example 7, and were then placed in water.
FIGS. 7 a to 7 c show the pictures taken at 5, 20 and 60 seconds after the cylinders being immersed in the water, from which it can be seen that the left cylinder made from the paste prepared in Control Example 1 collapses, while the right cylinder made form the paste prepared in Example 7 remains almost intact. - It can be concluded from the results shown in
FIGS. 5 a to 7 c that the paste prepared from the calcium phosphate cement of the present invention can be directly injected or implanted after being molded into a block into a cavity in a deformed tooth or bone. - Two samples of the calcium phosphate cement prepared in Example 7 were observed by transmission electron microscopy (TEM), and the two TEM pictures shown in
FIGS. 8 and 9 indicate that there are whiskers on surfaces of calcium phosphate particles having different diameters of the calcium phosphate cement. - The calcium phosphate cement prepared in Example 6 has a particle diameter distribution shown in
FIG. 1 , which was determined by using particle size analyzer (Sald-2001, Shimadzu Co., Japan). The curve inFIG. 1 indicates that the particle diameters of the calcium phosphate cement prepared in Example 6 range from about 0.47 microns to 93.49 microns.FIG. 2 shows a scanning electron microscopy (SEM) micrograph of the calcium phosphate cement prepared in Example 6. Moreover, the lengths and the widths of the whiskers or fine crystals on surfaces of the calcium phosphate particles prepared in Example 6 were determined directly from TEM (JXA-840, JEOL Co., Japan), and the results are shown inFIGS. 3 and 4 , respectively. As shown inFIGS. 3 and 4 , the lengths and widths of the of the whiskers or fine crystals on surfaces of the calcium phosphate particles prepared in Example 6 range from 1 to 625 nm and 1 to 65 nm, respectively. - The procedures of Example 7 were repeated by using the calcium phosphate powders and the wetting solutions listed in Table 2. The performance is also listed in Table 2.
TABLE 2 Setting/ Dis- Calcium Heating working persive phosphate Wetting treat- time in powder* solution ment (min) water Ex. 15 TCP Acetic acid Yes 10/6.5 No Control TCP — No Yes Ex. 2 Ex. 16 TCP Acetic acid Yes 12.5/8.5 No Control TCP — No — Yes Ex. 3 Ex. 17 TTCP + DCPA Phosphoric Yes 11/18 No acid Control TTCP + DCPA — No — Yes Ex. 4 Ex. 18 TTCP + DCPA + Phosphoric Yes — No TCP acid Control TTCP + DCPA + — No — Yes Ex. 5 TCP Ex. 19 DCPA + TCP Phosphoric Yes 29/24 No acid Control DCPA + TCP — No — Yes Ex. 6
*TCP is anhydrous tricalcium phosphate.
TTCP + DCPA is a mixed powder of TTCP and DCPA in 1:1 molar ratio.
TTCP + DCPA + TCP is a mixed powder of TTCP + DCPA and TCP in 1:1 weight ratio.
DCPA + TCP is a mixed powder of DCPA and TCP in 1:2 molar ratio.
DCPA + TCP is a mixed powder of DCPA and TCP in 1:2 molar ratio.
- The procedures of Control Example 1 were repeated by using the calcium phosphate powders and the wetting solutions listed in Table 2. The performance is also listed in Table 2.
- The procedures of Example 7 were repeated by using the wetting solutions having different pH values listed in Table 3. The performance is also listed in Table 3.
- The procedures of Control Example 1 were repeated by using the wetting solutions having different pH values listed in Table 3. The performance is also listed in Table 3.
TABLE 3 Heating Dispersive Wetting solution pH treatment in water Ex. 20 Phosphoric acid 0.56 Yes No Control Ex. 7 — — No Yes Ex. 21 Phosphoric acid 1.03 Yes No Ex. 22 Phosphoric acid 1.17 Yes No Ex. 23 Phosphoric acid 1.22 Yes No Ex. 24 Phosphoric acid 1.32 Yes No Ex. 25 Phosphoric acid 2.0 Yes No Control Ex. 8 — — No Yes Ex. 26 Acetic acid + sodium 7.0 Yes No carbonate Control Ex. 9 — — No Yes Ex. 27 Sodium hydroxide 9.5 Yes No Control Ex. 10 — — No Yes Ex. 28 Sodium hydroxide 12.55 Yes No Control Ex. 11 — — No Yes Ex. 29 Acetic acid 1.96 Yes No Control Ex. 12 — — No Yes Ex. 30 Ethanol — Yes No Control Ex. 13 — — No Yes Ex. 31 Deionized water 7.0 Yes No Control Ex. 14 — — No Yes
Claims (28)
1-45. (canceled)
46. A system for repairing a defect in a tooth or in a bone of a patient comprising:
calcium phosphate cement particles that are non-dispersive in an aqueous solution, wherein the diameter of the calcium phosphate cement particles is from about 0.05 microns to about 100 microns, wherein at least a portion of the calcium phosphate cement particles have surface whiskers comprising basic calcium phosphate crystals, and wherein the surface whiskers have a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm;
an aqueous solution, the aqueous solution comprising a hardening promoter; and
an injector configured to inject a paste formed by contacting the calcium phosphate cement particles with the aqueous solution into the defect in the bone or in the tooth.
47. The system of claim 46 , wherein the calcium phosphate cement particles comprise calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, tetracalcium phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, apatite and hydroxyapatite, or a mixture thereof.
48. The system of claim 46 , wherein the calcium phosphate cement particles comprise dicalcium phosphate anhydrous, tetracalcium phosphate, tricalcium phosphate, or mixtures thereof.
49. The system of claim 46 , wherein the aqueous solution further comprises a growth factor, a bone morphology protein, a pharmaceutical carrier, or mixtures thereof.
50. The system of claim 46 , further comprising a growth factor, a bone morphology protein, a pharmaceutical carrier, or mixtures thereof.
51. The system of claim 46 , wherein the hardening promoter comprises phosphate ions, calcium ions, fluorine ions, or mixtures thereof.
52. The system of claim 46 , wherein hardening-promoter comprises about 1 mM to about 3 M phosphate ions.
53. The system of claim 46 , wherein the pH of the aqueous solution is at least about 6.0.
54. The system of claim 46 , wherein the calcium phosphate cement particles have a diameter ranging from about 0.5 microns to about 50 microns, and wherein the whiskers or fine crystals have a length ranging from 10 nm to about 700 nm.
55. The system of claim 46 , wherein the calcium phosphate cement particles have a calcium to phosphate molar ratio ranging from about 0.5 to about 2.5.
56. The system of claim 46 , wherein the calcium phosphate cement particles have a calcium to phosphate molar ratio ranging from about 0.8 to about 2.3.
57. The system of claim 46 , wherein the calcium phosphate cement particles have a calcium to phosphate molar ratio ranging from about 1.0 to about 2.2.
58. A method of repairing a defect in a bone of a patient comprising:
contacting calcium phosphate cement particles with an aqueous solution comprising a hardening-promoter to form a non-dispersive, injectable paste;
shaping the paste, wherein the shaped paste is substantially complementary to the defect in the bone; and
implanting the shaped paste into the bone to repair the defect;
wherein the average diameter of the calcium phosphate cement particles is from about 0.05 microns to about 100 microns, wherein at least a portion of the calcium phosphate particles have surface whiskers comprising basic calcium phosphate crystals, and wherein the surface whiskers have a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm.
59. The method of claim 58 , wherein the calcium phosphate cement particles comprise calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, tetracalcium phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, apatite and hydroxyapatite, or mixtures thereof.
60. The method of claim 58 , wherein the calcium phosphate cement particles comprise dicalcium phosphate anhydrous, tetracalcium phosphate, tricalcium phosphate, or mixtures thereof.
61. The method of claim 58 , wherein the paste further comprises a growth factor, a bone morphology protein, a pharmaceutical carrier, or mixtures thereof.
62. The method of claim 58 , wherein the hardening-promoter comprises phosphate ions, calcium ions, fluorine ions, or mixtures thereof.
63. The method of claim 58 , wherein the aqueous solution comprises about 1 mM to about 3 M of the hardening promoter.
64. The method of claim 58 , wherein hardening-promoter comprises phosphate ions.
65. The method of claim 58 , wherein the pH of the aqueous solution is at least about 6.0.
66. The method of claim 58 , wherein the calcium phosphate cement particles have a diameter ranging from about 0.5 microns to about 50 microns.
67. The method of claim 58 , wherein the whiskers or fine crystals have a length ranging from about 10 nm to about 700 nm.
68. The method of claim 58 , wherein the calcium phosphate cement particles have a calcium to phosphate molar ratio ranging from about 0.5 to about 2.5.
69. The method of claim 58 , wherein the calcium phosphate particles have a calcium to phosphate molar ratio ranging from about 0.8 to about 2.3.
70. The method of claim 58 , wherein the calcium phosphate particles have a calcium to phosphate molar ratio ranging from about 1.0 to about 2.2.
71. The method of claim 58 , wherein the setting time of the injectable paste is adapted to be less than about 30 minutes.
72. The method of claim 58 , wherein the working time of the injectable paste is adapted to be less than about 25 minutes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/129,066 US20050271742A1 (en) | 1999-07-14 | 2005-05-13 | Injectable calcium phosphate cements and the preparation and use thereof |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/351,912 US6379453B1 (en) | 1999-07-14 | 1999-07-14 | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US61538400A | 2000-07-13 | 2000-07-13 | |
US10/328,019 US6840995B2 (en) | 1999-07-14 | 2002-12-26 | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US10/414,582 US7094282B2 (en) | 2000-07-13 | 2003-04-16 | Calcium phosphate cement, use and preparation thereof |
US11/129,066 US20050271742A1 (en) | 1999-07-14 | 2005-05-13 | Injectable calcium phosphate cements and the preparation and use thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/414,582 Continuation US7094282B2 (en) | 1999-07-14 | 2003-04-16 | Calcium phosphate cement, use and preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050271742A1 true US20050271742A1 (en) | 2005-12-08 |
Family
ID=35446277
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/414,582 Expired - Fee Related US7094282B2 (en) | 1999-07-14 | 2003-04-16 | Calcium phosphate cement, use and preparation thereof |
US11/129,063 Expired - Fee Related US7214265B2 (en) | 2000-07-13 | 2005-05-13 | Injectable calcium phosphate cements and the preparation and use thereof |
US11/129,066 Abandoned US20050271742A1 (en) | 1999-07-14 | 2005-05-13 | Injectable calcium phosphate cements and the preparation and use thereof |
US11/129,227 Expired - Fee Related US7258734B2 (en) | 1999-07-14 | 2005-05-13 | Injectable calcium phosphate cements and the preparation and use thereof |
US11/129,029 Active 2025-04-08 US7976874B2 (en) | 2000-07-13 | 2005-05-13 | Injectable calcium phosphate cements and the preparation and use thereof |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/414,582 Expired - Fee Related US7094282B2 (en) | 1999-07-14 | 2003-04-16 | Calcium phosphate cement, use and preparation thereof |
US11/129,063 Expired - Fee Related US7214265B2 (en) | 2000-07-13 | 2005-05-13 | Injectable calcium phosphate cements and the preparation and use thereof |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/129,227 Expired - Fee Related US7258734B2 (en) | 1999-07-14 | 2005-05-13 | Injectable calcium phosphate cements and the preparation and use thereof |
US11/129,029 Active 2025-04-08 US7976874B2 (en) | 2000-07-13 | 2005-05-13 | Injectable calcium phosphate cements and the preparation and use thereof |
Country Status (1)
Country | Link |
---|---|
US (5) | US7094282B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110152195A1 (en) * | 2009-12-18 | 2011-06-23 | Howmedica Osteonics Corp. | Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same |
WO2012101218A1 (en) * | 2011-01-26 | 2012-08-02 | Nanotecmarin Gmbh | Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases |
KR20140129058A (en) * | 2012-01-31 | 2014-11-06 | 더유니버시티오브톨레도 | Injectable, biodegradable bone cements and methods of making and using same |
US10182973B2 (en) | 2010-11-10 | 2019-01-22 | Stryker European Holdings I, Llc | Polymeric bone foam composition and method |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6960249B2 (en) * | 1999-07-14 | 2005-11-01 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface |
US7094282B2 (en) * | 2000-07-13 | 2006-08-22 | Calcitec, Inc. | Calcium phosphate cement, use and preparation thereof |
US7169373B2 (en) * | 1999-07-14 | 2007-01-30 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same |
US6840995B2 (en) * | 1999-07-14 | 2005-01-11 | Calcitec, Inc. | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US7270705B2 (en) * | 1999-07-14 | 2007-09-18 | Jiin-Huey Chern Lin | Method of increasing working time of tetracalcium phosphate cement paste |
US7204876B2 (en) * | 2000-07-13 | 2007-04-17 | Calcitec, Inc. | Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same |
US7156915B2 (en) * | 2000-07-13 | 2007-01-02 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) with surface whiskers and method of making same |
US6840961B2 (en) * | 2001-12-21 | 2005-01-11 | Etex Corporation | Machinable preformed calcium phosphate bone substitute material implants |
US20030216777A1 (en) * | 2002-05-16 | 2003-11-20 | Yin-Chun Tien | Method of enhancing healing of interfacial gap between bone and tendon or ligament |
US6994726B2 (en) * | 2004-05-25 | 2006-02-07 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
US7163651B2 (en) * | 2004-02-19 | 2007-01-16 | Calcitec, Inc. | Method for making a porous calcium phosphate article |
US7118705B2 (en) * | 2003-08-05 | 2006-10-10 | Calcitec, Inc. | Method for making a molded calcium phosphate article |
WO2005019102A1 (en) * | 2003-08-22 | 2005-03-03 | National Institute For Materials Science | Porous and spherical calcium phosphate particle being partly substituted with metal ion or having metal ion carried on surface thereof, and porous multiayer calcium phosphate particle |
EP1686934B1 (en) * | 2003-11-07 | 2020-03-18 | Vivex Biologics Group, Inc. | Injectable bone substitute |
EP1753748B1 (en) | 2004-05-12 | 2009-07-29 | Pfizer Products Inc. | Proline derivatives and their use as dipeptidyl peptidase iv inhibitors |
US7312989B2 (en) * | 2004-12-06 | 2007-12-25 | Chenbro Micom Co., Ltd. | Cooler |
BRPI0617086B8 (en) | 2005-09-09 | 2021-06-22 | Agnovos Healtcare Llc | bone graft substitute composite cement and articles originated from it |
US8025903B2 (en) | 2005-09-09 | 2011-09-27 | Wright Medical Technology, Inc. | Composite bone graft substitute cement and articles produced therefrom |
DE102006013854B4 (en) * | 2006-03-23 | 2010-08-19 | Heraeus Kulzer Gmbh | Use of a hydroxyapatite-forming material having a bioactive effect as a dental material |
JP5714896B2 (en) * | 2007-05-04 | 2015-05-07 | アセンディア アーベー | Osteoblast culture method and means |
CN102307941A (en) * | 2008-11-12 | 2012-01-04 | 好迈迪克奥斯迪里科斯公司 | Tetra calcium phosphate based organophosphorus compositions and methods |
US8106655B2 (en) * | 2009-05-29 | 2012-01-31 | The Invention Science Fund I, Llc | Multiplex imaging systems, devices, methods, and compositions including ferromagnetic structures |
US8058872B2 (en) | 2009-05-29 | 2011-11-15 | The Invention Science Fund I, Llc | Systems, devices, methods, and compositions including functionalized ferromagnetic structures |
US8154285B1 (en) | 2009-05-29 | 2012-04-10 | The Invention Science Fund I, Llc | Non-external static magnetic field imaging systems, devices, methods, and compositions |
US8063636B2 (en) * | 2009-05-29 | 2011-11-22 | The Invention Science Fund I, Llc | Systems, devices, methods, and compositions including targeted ferromagnetic structures |
US20100303733A1 (en) * | 2009-05-29 | 2010-12-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems, devices, methods, and compositions including ferromagnetic structures |
TWI427050B (en) * | 2009-06-12 | 2014-02-21 | Univ Kaohsiung Medical | Calcium phosphate bone cement, precursor thereof and fabrication method thereof |
EP2647383A4 (en) * | 2010-12-01 | 2016-01-27 | Sofsera Corp | Breast enhancement accelerator |
US8765189B2 (en) | 2011-05-13 | 2014-07-01 | Howmedica Osteonic Corp. | Organophosphorous and multivalent metal compound compositions and methods |
EP2744575A2 (en) * | 2011-08-19 | 2014-06-25 | Pioneer Surgical Technology, Inc. | Injectable fillers for aesthetic medical enhancement and for therapeutic applications |
US8906415B1 (en) * | 2011-10-26 | 2014-12-09 | The University Of Toledo | Calcium phosphate nanowhisker particles, method of making and using the same |
EP2773389A4 (en) | 2011-10-31 | 2015-09-16 | Univ Toledo | Method for modifying surfaces for better osseointegration |
EP2967799B1 (en) * | 2013-03-14 | 2020-09-02 | Osteoceramics, Inc. | Systems and methods of using chemically bound antibiotics activated by infections |
TWI651103B (en) | 2013-12-13 | 2019-02-21 | 萊特醫技股份有限公司 | Multiphase bone graft replacement material |
US20160324893A1 (en) * | 2015-05-06 | 2016-11-10 | Sunny Delight Beverages Co. | Calcium polyphosphate salts, methods of making and use in beverage compositions |
Citations (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3679360A (en) * | 1970-06-26 | 1972-07-25 | Nasa | Process for the preparation of brushite crystals |
US4371484A (en) * | 1980-06-13 | 1983-02-01 | Mitsubishi Mining & Cement Co., Ltd. | Process for making porous sintered body of calcium phosphate |
US4481175A (en) * | 1982-12-14 | 1984-11-06 | Mitsui Toatsu Chemicals, Inc. | Process for preparing apatite |
US4518430A (en) * | 1982-04-29 | 1985-05-21 | American Dental Association Health Foundation | Dental resptorative cement pastes |
US4612053A (en) * | 1983-10-06 | 1986-09-16 | American Dental Association Health Foundation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
US4623553A (en) * | 1984-06-12 | 1986-11-18 | Oscobal Ag | Method of producing a bone substitute material |
USRE33161E (en) * | 1982-04-29 | 1990-02-06 | American Dental Association Health Foundation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
USRE33221E (en) * | 1982-04-29 | 1990-05-22 | American Dental Association Health Foundation | Dental restorative cement pastes |
US4959104A (en) * | 1985-10-11 | 1990-09-25 | Mitsui Toatsu Chemicals, Inc. | Self-hardenable material |
US5017518A (en) * | 1987-09-14 | 1991-05-21 | Asahi Kogaku Kogyo K.K. | Process for producing calcium phosphate ceramics having porous surface |
US5053212A (en) * | 1988-04-20 | 1991-10-01 | Norian Corporation | Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite |
US5092888A (en) * | 1989-05-19 | 1992-03-03 | Tokuyama Soda Kabushiki Kaisha | Hardening material |
US5149368A (en) * | 1991-01-10 | 1992-09-22 | Liu Sung Tsuen | Resorbable bioactive calcium phosphate cement |
US5164187A (en) * | 1990-04-05 | 1992-11-17 | Norian Corporation | Hydroxyapatite prosthesis coatings |
US5180426A (en) * | 1987-12-28 | 1993-01-19 | Asahi Kogaku Kogyo K.K. | Composition for forming calcium phosphate type setting material and process for producing setting material |
US5262166A (en) * | 1991-04-17 | 1993-11-16 | Lty Medical Inc | Resorbable bioactive phosphate containing cements |
US5336264A (en) * | 1988-04-20 | 1994-08-09 | Norian Corporation | Situ prepared calcium phosphate composition and method |
US5338356A (en) * | 1991-10-29 | 1994-08-16 | Mitsubishi Materials Corporation | Calcium phosphate granular cement and method for producing same |
US5342441A (en) * | 1991-06-26 | 1994-08-30 | Nitta Gelatin Inc. | Biologically compatible hardening material for dental or medical applications |
US5409982A (en) * | 1990-07-27 | 1995-04-25 | Osaka Cement Co. Ltd. | Tetracalcium phosphate-based materials and process for their preparation |
US5492768A (en) * | 1992-10-08 | 1996-02-20 | Kyocera Corporation | Porous living body repairing member, and a method of imparting elasticity to it |
US5496399A (en) * | 1994-08-23 | 1996-03-05 | Norian Corporation | Storage stable calcium phosphate cements |
US5503164A (en) * | 1994-01-28 | 1996-04-02 | Osteogenics, Inc. | Device and method for repair of craniomaxillofacial bone defects including burr holes |
US5522893A (en) * | 1993-03-12 | 1996-06-04 | American Dental Association Health Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
US5525148A (en) * | 1993-09-24 | 1996-06-11 | American Dental Association Health Foundation | Self-setting calcium phosphate cements and methods for preparing and using them |
US5550172A (en) * | 1995-02-07 | 1996-08-27 | Ethicon, Inc. | Utilization of biocompatible adhesive/sealant materials for securing surgical devices |
US5605713A (en) * | 1991-11-22 | 1997-02-25 | Boltong; Maria G. | Process for the preparation of calcium phosphate cements and its application as bio-materials |
US5607685A (en) * | 1994-02-09 | 1997-03-04 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Protracted-release adminstration forms containing clindamycin palmitate |
US5683461A (en) * | 1995-05-19 | 1997-11-04 | Etex Corporation | Synthesis of reactive amorphous calcium phosphates |
US5766669A (en) * | 1995-08-24 | 1998-06-16 | Millenium Biologix Inc. | Sintering process for producing thin films of calcium phosphate entities |
US5782971A (en) * | 1991-06-28 | 1998-07-21 | Norian Corporation | Calcium phosphate cements comprising amorophous calcium phosphate |
US5814681A (en) * | 1994-10-13 | 1998-09-29 | Kuraray Co., Ltd. | Restorative composition for hard tissue and dispensing apparatus therefor |
US5891448A (en) * | 1995-01-06 | 1999-04-06 | American Dental Association Health Foundation | Control of calcium fluoride formation in mouth rinses, dentifrices and gels |
US5899939A (en) * | 1998-01-21 | 1999-05-04 | Osteotech, Inc. | Bone-derived implant for load-supporting applications |
US5958430A (en) * | 1998-02-20 | 1999-09-28 | Battelle Memorial Institute | Thin film composition with biological substance and method of making |
US5993535A (en) * | 1997-08-28 | 1999-11-30 | Ngk Spark Plug Co., Ltd. | Calcium phosphate cement and calcium phosphate cement composition |
US6013591A (en) * | 1997-01-16 | 2000-01-11 | Massachusetts Institute Of Technology | Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production |
US6018095A (en) * | 1996-06-14 | 2000-01-25 | Bioland | Method for preparing an implantable composite material, resulting material, implant including said material, and kit therefor |
US6027742A (en) * | 1995-05-19 | 2000-02-22 | Etex Corporation | Bioresorbable ceramic composites |
US6117456A (en) * | 1995-05-19 | 2000-09-12 | Etex Corporation | Methods and products related to the physical conversion of reactive amorphous calcium phosphate |
US6118043A (en) * | 1991-06-26 | 2000-09-12 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Bone replacement material with FGF |
US6123731A (en) * | 1998-02-06 | 2000-09-26 | Osteotech, Inc. | Osteoimplant and method for its manufacture |
US6132463A (en) * | 1995-05-19 | 2000-10-17 | Etex Corporation | Cell seeding of ceramic compositions |
US6149688A (en) * | 1995-06-07 | 2000-11-21 | Surgical Dynamics, Inc. | Artificial bone graft implant |
US6277149B1 (en) * | 1999-06-08 | 2001-08-21 | Osteotech, Inc. | Ramp-shaped intervertebral implant |
US6294187B1 (en) * | 1999-02-23 | 2001-09-25 | Osteotech, Inc. | Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same |
US6323146B1 (en) * | 1995-09-01 | 2001-11-27 | Millenium Biologix, Inc. | Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity |
US6340648B1 (en) * | 1999-04-13 | 2002-01-22 | Toshiba Ceramics Co., Ltd. | Calcium phosphate porous sintered body and production thereof |
US20020019635A1 (en) * | 2000-06-28 | 2002-02-14 | Wenstrom Richard F. | Method for fixing a graft in a bone tunnel |
US6379453B1 (en) * | 1999-07-14 | 2002-04-30 | Jiin-Huey Chern | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US20020073894A1 (en) * | 2000-10-16 | 2002-06-20 | University Of South Carolina Research Foundation | Biocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement |
US20020137812A1 (en) * | 2001-01-24 | 2002-09-26 | American Dental Association Health Foundation | Premixed calcium phosphate cement pastes |
US6478825B1 (en) * | 2001-11-28 | 2002-11-12 | Osteotech, Inc. | Implant, method of making same and use of the implant for the treatment of bone defects |
US20030019396A1 (en) * | 2000-10-30 | 2003-01-30 | Howmedica Osteonics Corp. | Porous calcium phosphate cement |
US20030031698A1 (en) * | 2000-01-31 | 2003-02-13 | Roeder Ryan K. | Composite biomaterial including anisometric calcium phosphate reinforcement particles and related methods |
US20030039676A1 (en) * | 1999-02-23 | 2003-02-27 | Boyce Todd M. | Shaped load-bearing osteoimplant and methods of making same |
US20030055512A1 (en) * | 2001-05-21 | 2003-03-20 | Genin Francois Y. | Calcium based neutral and bioresorbable bone graft |
US20030078317A1 (en) * | 2001-08-30 | 2003-04-24 | Jiin-Huey Lin | Process for preparing a paste from calcium phosphate cement |
US6569489B1 (en) * | 1998-03-11 | 2003-05-27 | Depuy Orthopaedics, Inc. | Bioactive ceramic coating and method |
US20030121450A1 (en) * | 1999-07-14 | 2003-07-03 | Jiin-Huey Chern Lin | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US20030167093A1 (en) * | 2002-03-01 | 2003-09-04 | American Dental Association Health Foundation | Self-hardening calcium phosphate materials with high resistance to fracture, controlled strength histories and tailored macropore formation rates |
US20030216777A1 (en) * | 2002-05-16 | 2003-11-20 | Yin-Chun Tien | Method of enhancing healing of interfacial gap between bone and tendon or ligament |
US20040003757A1 (en) * | 1999-07-14 | 2004-01-08 | Cana Lab Corporation | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface |
US20040022825A1 (en) * | 2001-12-21 | 2004-02-05 | Lagow Richard J. | Calcium phosphate bone replacement materials and methods of use thereof |
US20040031420A1 (en) * | 2000-07-13 | 2004-02-19 | Lin Jiin-Huey Chern | Calcium phosphate cement, use and preparation thereof |
US6719989B1 (en) * | 1999-09-08 | 2004-04-13 | Pentax Corporation | Sustained release drug carrier, and method of manufacturing sustained release drug carrier |
US20040076685A1 (en) * | 2002-07-11 | 2004-04-22 | Merck Patent Gmbh | Method of preparing porous calcium phosphate morsels and granules via gelatin processing |
US6752831B2 (en) * | 2000-12-08 | 2004-06-22 | Osteotech, Inc. | Biocompatible osteogenic band for repair of spinal disorders |
US20040137032A1 (en) * | 2002-03-15 | 2004-07-15 | Wang Francis W. | Combinations of calcium phosphates, bone growth factors, and pore-forming additives as osteoconductive and osteoinductive composite bone grafts |
US20040175320A1 (en) * | 1999-07-14 | 2004-09-09 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same |
US20040180091A1 (en) * | 2003-03-13 | 2004-09-16 | Chang-Yi Lin | Carbonated hydroxyapatite-based microspherical composites for biomedical uses |
US20040185181A1 (en) * | 2000-12-07 | 2004-09-23 | Pentax Corporation | Porous sintered body of calcium phosphate-based ceramic and method for producing same |
US20040186481A1 (en) * | 2003-03-21 | 2004-09-23 | Cana Lab Corporation | Method for forming a hardened cement in a bone cavity |
US6808585B2 (en) * | 2000-07-03 | 2004-10-26 | Osteotech, Inc. | Osteogenic implants derived from bone |
US20050008759A1 (en) * | 2003-07-11 | 2005-01-13 | Li Nie | Grain protein-based formulations and methods of using same |
US20050069479A1 (en) * | 1999-07-14 | 2005-03-31 | Calcitec, Inc. | Method of increasing working time of tetracalcium phosphate cement paste |
US20050186354A1 (en) * | 2004-02-19 | 2005-08-25 | Lin Jiin-Huey C. | Method for making a porous calcium phosphate article |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4553272A (en) | 1981-02-26 | 1985-11-19 | University Of Pittsburgh | Regeneration of living tissues by growth of isolated cells in porous implant and product thereof |
JPS63125259A (en) | 1986-11-14 | 1988-05-28 | 旭光学工業株式会社 | Calcium phosphate type porous bone filler |
US5342411A (en) * | 1988-04-16 | 1994-08-30 | Greater Glasgow Health Board | Scalp cooling device |
US6005162A (en) | 1988-04-20 | 1999-12-21 | Norian Corporation | Methods of repairing bone |
US5152791A (en) * | 1989-12-07 | 1992-10-06 | Olympus Optical Co., Ltd. | Prosthetic artificial bone having ceramic layers of different porosity |
US5218035A (en) * | 1992-02-03 | 1993-06-08 | Liu Sung Tsuen | Phosphate-containing surgical cements |
US6013853A (en) * | 1992-02-14 | 2000-01-11 | The University Of Texas System | Continuous release polymeric implant carrier |
JP3170059B2 (en) | 1992-08-25 | 2001-05-28 | 誠 大塚 | Calcium phosphate drug sustained-release body and method for producing the same |
US5550192A (en) * | 1992-12-07 | 1996-08-27 | Lyondell Petrochemical Company | Dyeable polyolefin compositions and dyeing polyolefin compositions |
US5476647A (en) * | 1993-09-13 | 1995-12-19 | American Dental Association Health Foundation | Complex calcium and fluoride containing mouth rinses, dentifrices, and chewable tablets |
US5702449A (en) | 1995-06-07 | 1997-12-30 | Danek Medical, Inc. | Reinforced porous spinal implants |
EP0906128A1 (en) * | 1996-05-28 | 1999-04-07 | 1218122 Ontario Inc. | Resorbable implant biomaterial made of condensed calcium phosphate particles |
US6953594B2 (en) | 1996-10-10 | 2005-10-11 | Etex Corporation | Method of preparing a poorly crystalline calcium phosphate and methods of its use |
CN1244815A (en) * | 1996-12-13 | 2000-02-16 | 诺瑞安有限公司 | Preparation, storage and administration of cements |
US5939039A (en) * | 1997-01-16 | 1999-08-17 | Orthovita, Inc. | Methods for production of calcium phosphate |
US6045551A (en) * | 1998-02-06 | 2000-04-04 | Bonutti; Peter M. | Bone suture |
SE515695C2 (en) * | 1999-05-31 | 2001-09-24 | Nobel Biocare Ab | Implant with coating of bone growth stimulant for bone application and procedure in such implant |
US6458162B1 (en) | 1999-08-13 | 2002-10-01 | Vita Special Purpose Corporation | Composite shaped bodies and methods for their production and use |
US6162258A (en) * | 1999-08-25 | 2000-12-19 | Osteotech, Inc. | Lyophilized monolithic bone implant and method for treating bone |
FR2805748B1 (en) * | 2000-03-01 | 2002-09-13 | Ceravic | PROCESS FOR THE PREPARATION OF AN INJECTABLE PHOSPHOCALCIC PASTE MATERIAL FOR FORMING AN APATITIC BIOMATERIAL AND SURGICAL OR DENTAL APPLICATION |
EP1153621A1 (en) | 2000-05-12 | 2001-11-14 | MERCK PATENT GmbH | Biocements based on a mixture of TCP-PHA with improved compressive strength |
US6533821B1 (en) * | 2000-06-22 | 2003-03-18 | Thomas Lally | Bio-adhesive composition, method for adhering objects to bone |
US6332779B1 (en) * | 2000-07-03 | 2001-12-25 | Osteotech, Inc. | Method of hard tissue repair |
US20020062154A1 (en) * | 2000-09-22 | 2002-05-23 | Ayers Reed A. | Non-uniform porosity tissue implant |
US6840961B2 (en) * | 2001-12-21 | 2005-01-11 | Etex Corporation | Machinable preformed calcium phosphate bone substitute material implants |
US6648960B1 (en) * | 2002-06-26 | 2003-11-18 | Cana Lab Corporation | Method of shortening a working and setting time of a calcium phosphate cement (CPC) paste |
CA2438742C (en) * | 2002-08-27 | 2011-08-09 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | A new calcium phosphate cement composition and a method for the preparation thereof |
US7118705B2 (en) * | 2003-08-05 | 2006-10-10 | Calcitec, Inc. | Method for making a molded calcium phosphate article |
US6994726B2 (en) * | 2004-05-25 | 2006-02-07 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
EP1686934B1 (en) * | 2003-11-07 | 2020-03-18 | Vivex Biologics Group, Inc. | Injectable bone substitute |
-
2003
- 2003-04-16 US US10/414,582 patent/US7094282B2/en not_active Expired - Fee Related
-
2005
- 2005-05-13 US US11/129,063 patent/US7214265B2/en not_active Expired - Fee Related
- 2005-05-13 US US11/129,066 patent/US20050271742A1/en not_active Abandoned
- 2005-05-13 US US11/129,227 patent/US7258734B2/en not_active Expired - Fee Related
- 2005-05-13 US US11/129,029 patent/US7976874B2/en active Active
Patent Citations (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3679360A (en) * | 1970-06-26 | 1972-07-25 | Nasa | Process for the preparation of brushite crystals |
US4371484A (en) * | 1980-06-13 | 1983-02-01 | Mitsubishi Mining & Cement Co., Ltd. | Process for making porous sintered body of calcium phosphate |
US4518430A (en) * | 1982-04-29 | 1985-05-21 | American Dental Association Health Foundation | Dental resptorative cement pastes |
USRE33161E (en) * | 1982-04-29 | 1990-02-06 | American Dental Association Health Foundation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
USRE33221E (en) * | 1982-04-29 | 1990-05-22 | American Dental Association Health Foundation | Dental restorative cement pastes |
US4481175A (en) * | 1982-12-14 | 1984-11-06 | Mitsui Toatsu Chemicals, Inc. | Process for preparing apatite |
US4612053A (en) * | 1983-10-06 | 1986-09-16 | American Dental Association Health Foundation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
US4623553A (en) * | 1984-06-12 | 1986-11-18 | Oscobal Ag | Method of producing a bone substitute material |
US4959104A (en) * | 1985-10-11 | 1990-09-25 | Mitsui Toatsu Chemicals, Inc. | Self-hardenable material |
US5017518A (en) * | 1987-09-14 | 1991-05-21 | Asahi Kogaku Kogyo K.K. | Process for producing calcium phosphate ceramics having porous surface |
US5180426A (en) * | 1987-12-28 | 1993-01-19 | Asahi Kogaku Kogyo K.K. | Composition for forming calcium phosphate type setting material and process for producing setting material |
US5053212A (en) * | 1988-04-20 | 1991-10-01 | Norian Corporation | Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite |
US5336264A (en) * | 1988-04-20 | 1994-08-09 | Norian Corporation | Situ prepared calcium phosphate composition and method |
US5820632A (en) * | 1988-04-20 | 1998-10-13 | Norian Corporation | Prepared calcium phosphate composition and method |
US5092888A (en) * | 1989-05-19 | 1992-03-03 | Tokuyama Soda Kabushiki Kaisha | Hardening material |
US5164187A (en) * | 1990-04-05 | 1992-11-17 | Norian Corporation | Hydroxyapatite prosthesis coatings |
US5569490A (en) * | 1990-07-27 | 1996-10-29 | Osaka Cement Co., Ltd. | Tetracalcium phosphate-based materials and processes for their preparation |
US5652016A (en) * | 1990-07-27 | 1997-07-29 | Osaka Cement Co., Ltd. | Tetracalcium phosphate-based materials and processes for their preparation |
US5536575A (en) * | 1990-07-27 | 1996-07-16 | Osaka Cement Co., Ltd. | Tetracalcium phosphate-based materials and processes for their preparation |
US5409982A (en) * | 1990-07-27 | 1995-04-25 | Osaka Cement Co. Ltd. | Tetracalcium phosphate-based materials and process for their preparation |
US5149368A (en) * | 1991-01-10 | 1992-09-22 | Liu Sung Tsuen | Resorbable bioactive calcium phosphate cement |
US5262166A (en) * | 1991-04-17 | 1993-11-16 | Lty Medical Inc | Resorbable bioactive phosphate containing cements |
US5342441A (en) * | 1991-06-26 | 1994-08-30 | Nitta Gelatin Inc. | Biologically compatible hardening material for dental or medical applications |
US6118043A (en) * | 1991-06-26 | 2000-09-12 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Bone replacement material with FGF |
US5782971B1 (en) * | 1991-06-28 | 1999-09-21 | Norian Corp | Calcium phosphate cements comprising amorophous calcium phosphate |
US5782971A (en) * | 1991-06-28 | 1998-07-21 | Norian Corporation | Calcium phosphate cements comprising amorophous calcium phosphate |
US5338356A (en) * | 1991-10-29 | 1994-08-16 | Mitsubishi Materials Corporation | Calcium phosphate granular cement and method for producing same |
US5605713A (en) * | 1991-11-22 | 1997-02-25 | Boltong; Maria G. | Process for the preparation of calcium phosphate cements and its application as bio-materials |
US5492768A (en) * | 1992-10-08 | 1996-02-20 | Kyocera Corporation | Porous living body repairing member, and a method of imparting elasticity to it |
US5545254A (en) * | 1993-03-12 | 1996-08-13 | The American Dental Association Health Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
US5542973A (en) * | 1993-03-12 | 1996-08-06 | The American Dental Association Health Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
US5522893A (en) * | 1993-03-12 | 1996-06-04 | American Dental Association Health Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
US5976234A (en) * | 1993-09-24 | 1999-11-02 | American Dental Association Health Foundation | Self-setting calcium phosphate cements and methods for preparing and using them |
US5954867A (en) * | 1993-09-24 | 1999-09-21 | American Dental Health Foundation Association | Self setting calcium phosphate cements and methods for preparing and using them |
US5525148A (en) * | 1993-09-24 | 1996-06-11 | American Dental Association Health Foundation | Self-setting calcium phosphate cements and methods for preparing and using them |
US5503164A (en) * | 1994-01-28 | 1996-04-02 | Osteogenics, Inc. | Device and method for repair of craniomaxillofacial bone defects including burr holes |
US5607685A (en) * | 1994-02-09 | 1997-03-04 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Protracted-release adminstration forms containing clindamycin palmitate |
US5683496A (en) * | 1994-08-23 | 1997-11-04 | Norian Corporation | Storage stable calcium phosphate cements |
US5496399A (en) * | 1994-08-23 | 1996-03-05 | Norian Corporation | Storage stable calcium phosphate cements |
US5964932A (en) * | 1994-08-23 | 1999-10-12 | Norian Corporation | Storage stable calcium phosphate cements |
US5814681A (en) * | 1994-10-13 | 1998-09-29 | Kuraray Co., Ltd. | Restorative composition for hard tissue and dispensing apparatus therefor |
US5891448A (en) * | 1995-01-06 | 1999-04-06 | American Dental Association Health Foundation | Control of calcium fluoride formation in mouth rinses, dentifrices and gels |
US5550172A (en) * | 1995-02-07 | 1996-08-27 | Ethicon, Inc. | Utilization of biocompatible adhesive/sealant materials for securing surgical devices |
US6027742A (en) * | 1995-05-19 | 2000-02-22 | Etex Corporation | Bioresorbable ceramic composites |
US6132463A (en) * | 1995-05-19 | 2000-10-17 | Etex Corporation | Cell seeding of ceramic compositions |
US5683461A (en) * | 1995-05-19 | 1997-11-04 | Etex Corporation | Synthesis of reactive amorphous calcium phosphates |
US6117456A (en) * | 1995-05-19 | 2000-09-12 | Etex Corporation | Methods and products related to the physical conversion of reactive amorphous calcium phosphate |
US6149688A (en) * | 1995-06-07 | 2000-11-21 | Surgical Dynamics, Inc. | Artificial bone graft implant |
US5766669A (en) * | 1995-08-24 | 1998-06-16 | Millenium Biologix Inc. | Sintering process for producing thin films of calcium phosphate entities |
US6585992B2 (en) * | 1995-09-01 | 2003-07-01 | Millenium Biologix, Inc. | Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity |
US6323146B1 (en) * | 1995-09-01 | 2001-11-27 | Millenium Biologix, Inc. | Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity |
US6018095A (en) * | 1996-06-14 | 2000-01-25 | Bioland | Method for preparing an implantable composite material, resulting material, implant including said material, and kit therefor |
US6013591A (en) * | 1997-01-16 | 2000-01-11 | Massachusetts Institute Of Technology | Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production |
US5993535A (en) * | 1997-08-28 | 1999-11-30 | Ngk Spark Plug Co., Ltd. | Calcium phosphate cement and calcium phosphate cement composition |
US5899939A (en) * | 1998-01-21 | 1999-05-04 | Osteotech, Inc. | Bone-derived implant for load-supporting applications |
US6123731A (en) * | 1998-02-06 | 2000-09-26 | Osteotech, Inc. | Osteoimplant and method for its manufacture |
US6294041B1 (en) * | 1998-02-06 | 2001-09-25 | Osteotech, Inc. | Method for an osteoimplant manufacture |
US5958430A (en) * | 1998-02-20 | 1999-09-28 | Battelle Memorial Institute | Thin film composition with biological substance and method of making |
US6569489B1 (en) * | 1998-03-11 | 2003-05-27 | Depuy Orthopaedics, Inc. | Bioactive ceramic coating and method |
US6440444B2 (en) * | 1999-02-23 | 2002-08-27 | Osteotech, Inc. | Load bearing osteoimplant and method of repairing bone using the same |
US20030039676A1 (en) * | 1999-02-23 | 2003-02-27 | Boyce Todd M. | Shaped load-bearing osteoimplant and methods of making same |
US6696073B2 (en) * | 1999-02-23 | 2004-02-24 | Osteotech, Inc. | Shaped load-bearing osteoimplant and methods of making same |
US6294187B1 (en) * | 1999-02-23 | 2001-09-25 | Osteotech, Inc. | Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same |
US6340648B1 (en) * | 1999-04-13 | 2002-01-22 | Toshiba Ceramics Co., Ltd. | Calcium phosphate porous sintered body and production thereof |
US6530955B2 (en) * | 1999-06-08 | 2003-03-11 | Osteotech, Inc. | Ramp-shaped intervertebral implant |
US6277149B1 (en) * | 1999-06-08 | 2001-08-21 | Osteotech, Inc. | Ramp-shaped intervertebral implant |
US20050069479A1 (en) * | 1999-07-14 | 2005-03-31 | Calcitec, Inc. | Method of increasing working time of tetracalcium phosphate cement paste |
US20040175320A1 (en) * | 1999-07-14 | 2004-09-09 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same |
US6840995B2 (en) * | 1999-07-14 | 2005-01-11 | Calcitec, Inc. | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US6379453B1 (en) * | 1999-07-14 | 2002-04-30 | Jiin-Huey Chern | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US20040003757A1 (en) * | 1999-07-14 | 2004-01-08 | Cana Lab Corporation | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface |
US20030121450A1 (en) * | 1999-07-14 | 2003-07-03 | Jiin-Huey Chern Lin | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US20050076813A1 (en) * | 1999-07-14 | 2005-04-14 | Calcitec, Inc. | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US6719989B1 (en) * | 1999-09-08 | 2004-04-13 | Pentax Corporation | Sustained release drug carrier, and method of manufacturing sustained release drug carrier |
US20030031698A1 (en) * | 2000-01-31 | 2003-02-13 | Roeder Ryan K. | Composite biomaterial including anisometric calcium phosphate reinforcement particles and related methods |
US20020019635A1 (en) * | 2000-06-28 | 2002-02-14 | Wenstrom Richard F. | Method for fixing a graft in a bone tunnel |
US6808585B2 (en) * | 2000-07-03 | 2004-10-26 | Osteotech, Inc. | Osteogenic implants derived from bone |
US20040031420A1 (en) * | 2000-07-13 | 2004-02-19 | Lin Jiin-Huey Chern | Calcium phosphate cement, use and preparation thereof |
US6808561B2 (en) * | 2000-10-16 | 2004-10-26 | University Of South Carolina | Biocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement |
US20020073894A1 (en) * | 2000-10-16 | 2002-06-20 | University Of South Carolina Research Foundation | Biocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement |
US6547866B1 (en) * | 2000-10-30 | 2003-04-15 | Howmedica Osteonics Corp. | Porous calcium phosphate cement |
US20030019396A1 (en) * | 2000-10-30 | 2003-01-30 | Howmedica Osteonics Corp. | Porous calcium phosphate cement |
US20040185181A1 (en) * | 2000-12-07 | 2004-09-23 | Pentax Corporation | Porous sintered body of calcium phosphate-based ceramic and method for producing same |
US6752831B2 (en) * | 2000-12-08 | 2004-06-22 | Osteotech, Inc. | Biocompatible osteogenic band for repair of spinal disorders |
US6793725B2 (en) * | 2001-01-24 | 2004-09-21 | Ada Foundation | Premixed calcium phosphate cement pastes |
US20020137812A1 (en) * | 2001-01-24 | 2002-09-26 | American Dental Association Health Foundation | Premixed calcium phosphate cement pastes |
US20030055512A1 (en) * | 2001-05-21 | 2003-03-20 | Genin Francois Y. | Calcium based neutral and bioresorbable bone graft |
US6616742B2 (en) * | 2001-08-30 | 2003-09-09 | Cana Lab Corporation | Process for preparing a paste from calcium phosphate cement |
US20030078317A1 (en) * | 2001-08-30 | 2003-04-24 | Jiin-Huey Lin | Process for preparing a paste from calcium phosphate cement |
US6478825B1 (en) * | 2001-11-28 | 2002-11-12 | Osteotech, Inc. | Implant, method of making same and use of the implant for the treatment of bone defects |
US20040022825A1 (en) * | 2001-12-21 | 2004-02-05 | Lagow Richard J. | Calcium phosphate bone replacement materials and methods of use thereof |
US20030167093A1 (en) * | 2002-03-01 | 2003-09-04 | American Dental Association Health Foundation | Self-hardening calcium phosphate materials with high resistance to fracture, controlled strength histories and tailored macropore formation rates |
US20040137032A1 (en) * | 2002-03-15 | 2004-07-15 | Wang Francis W. | Combinations of calcium phosphates, bone growth factors, and pore-forming additives as osteoconductive and osteoinductive composite bone grafts |
US20030216777A1 (en) * | 2002-05-16 | 2003-11-20 | Yin-Chun Tien | Method of enhancing healing of interfacial gap between bone and tendon or ligament |
US20040076685A1 (en) * | 2002-07-11 | 2004-04-22 | Merck Patent Gmbh | Method of preparing porous calcium phosphate morsels and granules via gelatin processing |
US20040180091A1 (en) * | 2003-03-13 | 2004-09-16 | Chang-Yi Lin | Carbonated hydroxyapatite-based microspherical composites for biomedical uses |
US20040186481A1 (en) * | 2003-03-21 | 2004-09-23 | Cana Lab Corporation | Method for forming a hardened cement in a bone cavity |
US20050008759A1 (en) * | 2003-07-11 | 2005-01-13 | Li Nie | Grain protein-based formulations and methods of using same |
US20050186354A1 (en) * | 2004-02-19 | 2005-08-25 | Lin Jiin-Huey C. | Method for making a porous calcium phosphate article |
US20050184417A1 (en) * | 2004-02-19 | 2005-08-25 | Cana Lab Corporation | Method for making a porous calcium phosphate article |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8481065B2 (en) | 2009-12-18 | 2013-07-09 | Howmedica Osteonics Corp. | Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same |
US20110152195A1 (en) * | 2009-12-18 | 2011-06-23 | Howmedica Osteonics Corp. | Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same |
US8722073B2 (en) | 2009-12-18 | 2014-05-13 | Howmedica Osteonics Corp. | Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same |
US10182973B2 (en) | 2010-11-10 | 2019-01-22 | Stryker European Holdings I, Llc | Polymeric bone foam composition and method |
US11185475B2 (en) | 2010-11-10 | 2021-11-30 | Stryker European Operations Holdings Llc | Polymeric bone foam composition and method |
EP2489346A1 (en) * | 2011-01-26 | 2012-08-22 | NanotecMARIN GmbH | Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases |
WO2012101218A1 (en) * | 2011-01-26 | 2012-08-02 | Nanotecmarin Gmbh | Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases |
KR20140129058A (en) * | 2012-01-31 | 2014-11-06 | 더유니버시티오브톨레도 | Injectable, biodegradable bone cements and methods of making and using same |
US20150005392A1 (en) | 2012-01-31 | 2015-01-01 | The University Of Toledo | Injectable, Biodegradable Bone Cements and Methods of Making and Using Same |
US20160199532A1 (en) * | 2012-01-31 | 2016-07-14 | The University Of Toledo | Injectable, Biodegradable Bone Cements and Methods of Making and Using Same |
US20160199533A1 (en) * | 2012-01-31 | 2016-07-14 | The University Of Toledo | Injectable, Biodegradable Bone Cements and Methods of Making and Using Same |
AU2016204525B2 (en) * | 2012-01-31 | 2017-07-13 | The University Of Toledo | Injectable, biodegradable bone cements and methods of making and using same |
US10052402B2 (en) * | 2012-01-31 | 2018-08-21 | The University Of Toledo | Injectable, biodegradable bone cements and methods of making and using same |
US10052403B2 (en) * | 2012-01-31 | 2018-08-21 | The University Of Toledo | Injectable, biodegradable bone cements and methods of making and using same |
US10342893B2 (en) | 2012-01-31 | 2019-07-09 | The University Of Toledo | Injectable, biodegradable bone cements and methods of making and using same |
KR102160719B1 (en) * | 2012-01-31 | 2020-09-29 | 더유니버시티오브톨레도 | Injectable, biodegradable bone cements and methods of making and using same |
Also Published As
Publication number | Publication date |
---|---|
US20040031420A1 (en) | 2004-02-19 |
US20050271741A1 (en) | 2005-12-08 |
US20050271740A1 (en) | 2005-12-08 |
US7094282B2 (en) | 2006-08-22 |
US7976874B2 (en) | 2011-07-12 |
US7258734B2 (en) | 2007-08-21 |
US7214265B2 (en) | 2007-05-08 |
US20050268819A1 (en) | 2005-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7258734B2 (en) | Injectable calcium phosphate cements and the preparation and use thereof | |
US6616742B2 (en) | Process for preparing a paste from calcium phosphate cement | |
WO2004094335A1 (en) | Calcium phosphate cement, use and preparation thereof | |
US5149368A (en) | Resorbable bioactive calcium phosphate cement | |
JP5383961B2 (en) | Brush stone hydraulic cement stabilized with magnesium salt | |
EP1715829B1 (en) | Rapid-hardening calcium phosphate cement compositions | |
US6379453B1 (en) | Process for producing fast-setting, bioresorbable calcium phosphate cements | |
CA2306562A1 (en) | Hydraulic surgical cement | |
US9913931B2 (en) | Cement-forming compositions, monetite cements, implants and methods for correcting bone defects | |
CA2555240A1 (en) | Method of increasing working time ttcp | |
US7169373B2 (en) | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same | |
US6648960B1 (en) | Method of shortening a working and setting time of a calcium phosphate cement (CPC) paste | |
EP0945119B1 (en) | Calcium phosphate cements | |
EP1172076A2 (en) | Calcium phosphate cement, use and preparation thereof | |
Alge et al. | Characterization of dicalcium phosphate dihydrate cements prepared using a novel hydroxyapatite-based formulation | |
JP3574396B2 (en) | Calcium phosphate cement, its use and production method | |
KR20060091714A (en) | Calcium phosphate cement, use and preparation thereof | |
AU2004232948A1 (en) | Calcium phosphate cement, use and preparation thereof | |
JPH06172008A (en) | Hardenable composition | |
US7182928B2 (en) | Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same | |
JPH1111997A (en) | Production of calcium phosphate cement and calcium phosphate cement hardened body | |
JPH1111998A (en) | Quick hardening calcium phosphate cement and its production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CANA LAB CORPORATION, TAIWAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIN, JIIN-HUEY CHERN;JU, CHIEN-PING;CHEN, WEN-CHENG;REEL/FRAME:016901/0974;SIGNING DATES FROM 20030817 TO 20030820 Owner name: CALCITEC, INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CANA LAB CORPORATION;REEL/FRAME:016901/0966 Effective date: 20040314 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |